| Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy RM Brotman, MD Shardell, P Gajer, D Fadrosh, K Chang, MI Silver, ... Menopause 21 (5), 450-458, 2014 | 469 | 2014 |
| Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women AF Rositch, AE Burke, RP Viscidi, MI Silver, K Chang, PE Gravitt Cancer research 72 (23), 6183-6190, 2012 | 152 | 2012 |
| Differences in the concentration and correlation of cervical immune markers among HPV positive and negative perimenopausal women MA Marks, RP Viscidi, K Chang, M Silver, A Burke, R Howard, PE Gravitt Cytokine 56 (3), 798-803, 2011 | 145 | 2011 |
| A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States PE Gravitt, AF Rositch, MI Silver, MA Marks, K Chang, AE Burke, ... Journal of Infectious Diseases 207 (2), 272-280, 2013 | 130 | 2013 |
| Evidence-based consensus recommendations for colposcopy practice for cervical cancer prevention in the United States N Wentzensen, LS Massad, EJ Mayeaux Jr, MJ Khan, AG Waxman, ... Journal of lower genital tract disease 21 (4), 216-222, 2017 | 117 | 2017 |
| Determinants of VIA (Visual Inspection of the Cervix After Acetic Acid Application) positivity in cervical cancer screening of women in a peri-urban area in Andhra Pradesh, India H Vedantham, MI Silver, B Kalpana, C Rekha, BP Karuna, K Vidyadhari, ... Cancer epidemiology, biomarkers & prevention 19 (5), 1373-1380, 2010 | 95 | 2010 |
| ASCCP colposcopy standards: risk-based colposcopy practice N Wentzensen, M Schiffman, MI Silver, MJ Khan, RB Perkins, KM Smith, ... Journal of lower genital tract disease 21 (4), 230-234, 2017 | 85 | 2017 |
| ASCCP colposcopy standards: how do we perform colposcopy? Implications for establishing standards AG Waxman, C Conageski, MI Silver, C Tedeschi, EA Stier, B Apgar, ... Journal of lower genital tract disease 21 (4), 235-241, 2017 | 60 | 2017 |
| Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening MI Silver, AF Rositch, AE Burke, K Chang, R Viscidi, PE Gravitt Obstetrics & Gynecology 125 (2), 317-329, 2015 | 52 | 2015 |
| Shedding of Epstein-Barr virus and cytomegalovirus from the genital tract of women in a periurban community in Andhra Pradesh, India MI Silver, P Paul, P Sowjanya, G Ramakrishna, H Vedantham, B Kalpana, ... Journal of clinical microbiology 49 (7), 2435-2439, 2011 | 48 | 2011 |
| Clinical outcomes after conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women ages 21–39 years MI Silver, JC Gage, M Schiffman, B Fetterman, NE Poitras, T Lorey, ... Cancer Prevention Research 11 (3), 165-170, 2018 | 44 | 2018 |
| Risk of cervical intraepithelial neoplasia 2 or worse by cytology, human papillomavirus 16/18, and colposcopy impression: a systematic review and meta-analysis MI Silver, J Andrews, CK Cooper, JC Gage, MA Gold, MJ Khan, ... Obstetrics & Gynecology 132 (3), 725-735, 2018 | 39 | 2018 |
| The correlation between human papillomavirus positivity and abnormal cervical cytology result differs by age among perimenopausal women AF Rositch, MI Silver, A Burke, R Viscidi, K Chang, CMP Duke, W Shen, ... Journal of lower genital tract disease 17 (1), 38-47, 2013 | 33 | 2013 |
| A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers N Wentzensen, J Walker, K Smith, MA Gold, R Zuna, LS Massad, A Liu, ... American journal of obstetrics and gynecology 218 (6), 604. e1-604. e8, 2018 | 31 | 2018 |
| Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30–65 years MI Silver, AF Rositch, DF Phelan-Emrick, PE Gravitt Cancer Causes & Control 29, 43-50, 2018 | 31 | 2018 |
| Preparing for the next round of ASCCP-sponsored cervical screening and management guidelines M Schiffman, N Wentzensen, MJ Khan, PE Castle, D Chelmow, WK Huh, ... Journal of lower genital tract disease 21 (2), 87-90, 2017 | 31 | 2017 |
| Achieving equity in cervical cancer screening in low-and middle-income countries (LMICs): Strengthening health systems using a systems thinking approach PE Gravitt, MI Silver, HM Hussey, S Arrossi, M Huchko, J Jeronimo, ... Preventive medicine 144, 106322, 2021 | 29 | 2021 |
| Cancer screening: health impact, prevalence, correlates, and interventions EA Sarma, MI Silver, SC Kobrin, PM Marcus, RA Ferrer Psychology & health 34 (9), 1036-1072, 2019 | 29 | 2019 |
| Rates of new human papillomavirus detection and loss of detection in middle-aged women by recent and past sexual behavior P Paul, A Hammer, AF Rositch, AE Burke, RP Viscidi, MI Silver, ... The Journal of infectious diseases 223 (8), 1423-1432, 2021 | 26 | 2021 |
| Exacerbating disparities?: cervical cancer screening and HPV vaccination MI Silver, S Kobrin Preventive medicine 130, 105902, 2020 | 23 | 2020 |
